William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 21,427 shares at $80.88 ($1.7M) on 2025-12-02, disclosed to the SEC on 2025-12-03.
Scheduled sale ($1.7M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 787 | $0 | 0.0% |
| 2 | $80.05 | 19,360 | $1.5M | 93.7% |
| 3 | $80.88 | 640 | $52K | 3.1% |
| 4 | $80.88 | 640 | $52K | 3.1% |
| Total | $77.16 avg | 21,427 | $1.7M | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |